Similar articles

• [Apolipoproteins are new and better risk indicators of myocardial infarction].

  Walldius G, Jungner I. Walldius G, et al. Lakartidningen. 2004 Mar 25;101(13):1188-94. Lakartidningen. 2004. PMID: 15101244 Review. Swedish.
• Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

  Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G. Sniderman AD, et al. J Intern Med. 2006 May;259(5):455-61. doi: 10.1111/j.1365-2796.2006.01649.x. J Intern Med. 2006. PMID: 16629851
• [Measurement of apolipoproteins is better than routinely measured traditional lipids].

  Kallner A, Estonius M. Kallner A, et al. Lakartidningen. 2006 Mar 8-14;103(10):753-6, 758. Lakartidningen. 2006. PMID: 16610202 Swedish. No abstract available.
• [Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].

  Wiklund O. Wiklund O. Lakartidningen. 2007 May 14-29;104(20-21):1623-4. Lakartidningen. 2007. PMID: 17564272 Swedish. No abstract available.
• The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.

  Walldius G, Jungner I. Walldius G, et al. J Intern Med. 2006 May;259(5):493-519. doi: 10.1111/j.1365-2796.2006.01643.x. J Intern Med. 2006. PMID: 16629855 Review.